Thyrocare Technologies informs about change in management

29 Nov 2025 Evaluate
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations), Thyrocare Technologies has informed that Nitin Chugh, Chief Commercial Officer and part of the Senior Management Personnel of Thyrocare Technologies have decided to pursue an opportunity outside the organization. He was appointed as Chief Commercial Officer of the Company, forming part of its Senior Management, with effect from February 1, 2024, and will complete his handover and cease to be associated with the Company with effect from the close of business hours on November 30, 2025. The Company has substantially progressed the process of identifying a suitable replacement for the said position. The details will be intimated to the Stock Exchanges in due course, in compliance with applicable laws. In compliance with Regulation 30 of the SEBI LODR Regulations and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, the requisite disclosure is enclosed as Annexure–1. The resignation letter submitted by Nitin Chugh is enclosed as Annexure-2.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

440.00 -18.45 (-4.02%)
17-Dec-2025 11:37 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6988.25
Max Healthcare Inst 1047.90
Narayana Hrudayalay 1874.00
Aster DM Healthcare 607.95
Global Health 1134.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×